tiprankstipranks
Artelo Biosciences Inc (ARTL)
NASDAQ:ARTL
US Market

Artelo Biosciences (ARTL) Financial Statements

442 Followers

Artelo Biosciences Financial Overview

Artelo Biosciences's market cap is currently ―. The company's EPS TTM is $-3.13; its P/E ratio is -0.46; Artelo Biosciences is scheduled to report earnings on August 7, 2024, and the estimated EPS forecast is $-0.79. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.48M$ -3.07M$ -2.45M$ -1.60M$ -2.20M
EBITDA$ -2.48M$ -3.07M$ -2.45M$ -1.60M$ -2.20M
Net Income Common Stockholders$ -2.48M$ -3.07M$ -2.45M$ -1.60M$ -2.20M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 6.41M$ 7.61M$ 10.22M$ 13.99M$ 15.48M
Total Assets$ 10.35M$ 13.04M$ 15.50M$ 16.88M$ 18.48M
Total Debt$ 127.00K$ 23.00K$ 32.00K$ 40.00K$ 52.00K
Net Debt$ -6.29M$ -7.59M$ -10.19M$ -13.95M$ -15.43M
Total Liabilities$ 817.00K$ 1.29M$ 921.00K$ 609.00K$ 840.00K
Stockholders Equity$ 9.54M$ 11.75M$ 14.58M$ 16.27M$ 17.64M
Cash Flow-
Free Cash Flow$ -2.94M$ -2.60M$ -1.80M$ -1.62M$ -2.19M
Operating Cash Flow$ -2.94M$ -2.60M$ -1.80M$ -1.62M$ -2.19M
Investing Cash Flow$ 1.27M$ 2.74M$ -1.83M$ 399.00K$ 2.20M
Financing Cash Flow$ 55.00K$ 32.00K$ 535.00K--
Currency in USD

Artelo Biosciences Earnings and Revenue History

Artelo Biosciences Debt to Assets

Artelo Biosciences Cash Flow

Artelo Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis